Introduction

Our Organ Modelling Congress addresses an important and expanding field which provides new understandings in organ functionality and novel approaches to drug development. These engineered human organs using Organ-on-a-Chip, Tissue-on-a-Chip & Organoids are a remarkable tool with the potential to facilitate studies that better predict drug efficacy and thereby reduce cost, time, and failure rates in clinical trials. Further, patient-derived organoids hold promise for personalised medicine, as they have the potential to produce individualised predictions of drug response.

Useful links

• Further event details More information about the event

Speakers

• Hansjoerg Keller Novartis Institutes for BioMedical Research, United Kingdom
• Linda Lieberman Merck & Co, United Kingdom
• Pelin Candarlioglu GlaxoSmithKline, United Kingdom
• Ron Weiss MIT, United Kingdom
• Sasha Mendjan IMBA Institute Of Molecular Biotechnology, United Kingdom
• Olivier T. Guenat University of Bern, United Kingdom

---

Venue

Novotel London West

Novotel London West, 1 Shortlands, Hammersmith International Centre, Hammersmith, London, W6 8DR, United Kingdom

Useful links

• Venue information More information about the venue

Organised by

Oxford Global

Contact information

Guillaume Alonso
Oxford Global
Contact us by email

---